Nephros, Inc.
NEPH
$4.19
$0.010.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.39% | 26.02% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.39% | 26.02% | |||
| Cost of Revenue | -5.75% | 23.51% | |||
| Gross Profit | -11.38% | 27.43% | |||
| SG&A Expenses | -2.35% | 20.41% | |||
| Depreciation & Amortization | -10.26% | 14.71% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.25% | 21.33% | |||
| Operating Income | -56.18% | 78.55% | |||
| Income Before Tax | -55.91% | 53.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -57.53% | 59.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -57.53% | 59.89% | |||
| EBIT | -56.18% | 78.55% | |||
| EBITDA | -53.63% | 72.16% | |||
| EPS Basic | -57.41% | 58.91% | |||
| Normalized Basic EPS | -55.93% | 52.31% | |||
| EPS Diluted | -60.00% | 51.06% | |||
| Normalized Diluted EPS | -56.84% | 52.31% | |||
| Average Basic Shares Outstanding | 0.00% | 0.53% | |||
| Average Diluted Shares Outstanding | 1.86% | 0.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||